AMINOSYN 3.5% M
LOE Approachingamino acids; magnesium acetate; phosphoric acid; potassium acetate; sodium chloride
NDAINJECTIONINJECTABLE
Approved
May 1976
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 6h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
AMINOSYN 3.5% M is an intravenous nutritional formulation combining essential and non-essential amino acids with electrolytes (magnesium acetate, potassium acetate, sodium chloride) and phosphoric acid. It is indicated for parenteral nutrition in patients unable to meet protein and micronutrient requirements orally or enterally. The formulation works by providing exogenous amino acids and electrolytes to support protein synthesis, cellular function, and electrolyte balance.
LOE Approaching
Approaching loss of exclusivity with moderate competitive pressure (30%), suggesting defensibility efforts and potential team consolidation.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on AMINOSYN 3.5% M offers a stable, defensive career opportunity in hospital-based nutrition support, with emphasis on operational excellence, cost containment, and customer retention. Career growth will center on supply chain leadership, manufacturing scale, and hospital relationship management rather than clinical development or commercial expansion.
Account Manager (Hospital Systems)
Worked on AMINOSYN 3.5% M at ICU Medical? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.